Photo via The Straits Times

White House pulls FDA chief nominee Heidi Overton before hearing, Axios says

Read the original at The Straits Times ↗
Cite

The Straits Times. (2026, November 18). White House pulls FDA chief nominee Heidi Overton before hearing, Axios says. The Straits Times. https://www.straitstimes.com/world/united-states/white-house-pulls-fda-chief-nominee-heidi-overton-before-hearing-axios-says

Dated from the outlet's own feed. Check the original for its byline.

The Straits Times · collected 2026-11-18 · by The Straits Times

Quick Summary

The White House has withdrawn Heidi Overton’s nomination to lead the US Food and Drug Administration (FDA) before her confirmation hearing, according to Axios. The decision was made due to a lack of congressional support, especially after criticism from a former Health Secretary’s adviser and opposition from several Republican senators. This move adds to the FDA’s ongoing leadership challenges, with the agency currently led temporarily by Kyle Diamantas.
Written by AI on 2026-11-18, from this article's own text only (the story summary below draws on all the coverage).
See how they differ ↓

AI analysis

Story summary

The White House withdrew Dr. Heidi Overton’s nomination to lead the Food and Drug Administration (FDA) on November 17, 2026, just before a scheduled Senate committee vote, due to lack of bipartisan support. Overton faced skepticism from some Republicans over her involvement in the administration's efforts to change childhood vaccine recommendations. To advance to the full Senate, Overton needed 11 votes from the 21-member committee, but she failed to secure the necessary Republican support. The decision leaves the FDA’s leadership vacancy unresolved, with Senate Democrats now likely to take the lead in selecting a new nominee.

Written for “White House Withdraws Heidi Overton’s FDA Nomination” on 2026-11-21, grounded in this article and the 16 other(s) covering the same event.

How they differ

13 outlets covered “White House Withdraws Heidi Overton’s FDA Nomination”.

What each outlet says

One AI summary per outlet of its latest article on this story, written from that article alone and checked against it. Open the article for the outlet's own words.

The Straits TimesThis outlet18 Nov

The White House has withdrawn Heidi Overton’s nomination to lead the US Food and Drug Administration (FDA) before her confirmation hearing, according to Axios. The decision was made due to a lack of congressional support, especially after criticism from a former Health Secretary’s adviser and opposition from several Republican senators. This move adds to the FDA’s ongoing leadership challenges, with the agency…

White House pulls FDA chief nominee Heidi Overton before hearing, Axios says (this article)
Semafor19 Nov

The FDA is facing a leadership gap as the White House has withdrawn Heidi Overton's nomination, likely preventing a replacement before the end of the year. This situation could lead to a series of temporary commissioners, such as Sara Brenner or Karim Mikhail, overseeing the agency's operations. The lack of a permanent leader complicates efforts to secure industry user fees, which provide half of the FDA’s funding…

FDA's long-term vacancy →3 articles from Semafor on this story
CBS News18 Nov

The White House has withdrawn Dr. Heidi Overton's nomination as the new FDA commissioner, a position she was selected for by President Trump. The Senate health committee was set to vote on her nomination on Wednesday, but the White House has since decided to remove her from consideration. Axios was the first to report this change.

White House drops Heidi Overton's nomination for FDA commissioner →2 articles from CBS News on this story
Fox News20 Nov

Erik Baptist, senior vice president of legal strategy at Susan B. Anthony Pro-Life America, told Fox News Digital that his organization pushed for the Senate to delay Heidi Overton's nomination to head the FDA until the Trump administration committed to ending mail-order access to abortion drugs and changing how the FDA studies the safety of those drugs. Baptist emphasized that pro-life states cannot enforce their…

Pro-life group says Trump admin didn't give key abortion drug commitments before Overton FDA nomination pulled →2 articles from Fox News on this story
New York Post18 Nov

The White House has withdrawn Heidi Overton’s nomination to lead the Food and Drug Administration (FDA) due to insufficient support from Senate lawmakers. Overton, a physician and deputy director of the White House Domestic Policy Council, faced significant opposition for her alleged ties to the tobacco industry, pro-vaping stance, and anti-abortion views. Critics demonstrated their disapproval by placing signs…

White House withdraws Heidi Overton’s FDA nomination after Trump pick received bipartisan pushback →
Toronto Star18 Nov

The White House has withdrawn Dr. Heidi Overton’s nomination to lead the Food and Drug Administration due to insufficient Senate Republican support. Overton, a Trump-aligned physician and White House domestic policy adviser, was nominated in August to replace Dr. Marty Makary, who had a controversial tenure. Her nomination was intended to stabilize the FDA with a Trump loyalist, but faced opposition that prevented…

White House pulls FDA nominee Heidi Overton after wavering support from Senate Republicans →
Show 7 more outlets
NBC News18 Nov

The White House has withdrawn Dr. Heidi Overton’s nomination to become the FDA commissioner due to Republican senators' concerns about her lack of managerial experience. The decision came shortly before Overton’s scheduled Senate Health Committee vote, where she needed at least one Republican vote to advance. Senators Cassidy, Collins, and Murkowski expressed reservations about Overton’s qualifications and her…

White House drops Heidi Overton’s FDA nomination →
ABC News (US)18 Nov

Dr. Heidi Overton's nomination to become the FDA commissioner was withdrawn on Tuesday after facing significant opposition from some Republican senators. The nomination encountered hurdles primarily due to Overton’s positions on abortion, vaccines, and vaping, according to sources familiar with the situation.

Trump's pick Heidi Overton dropped as nominee for FDA commissioner →
Just the News18 Nov

The White House has withdrawn Heidi Overton's nomination to lead the Food and Drug Administration (FDA) just one day before her scheduled vote by the Senate Health, Education, Labor and Pensions Committee. Overton, a physician and deputy director of the White House Domestic Policy Council, faced skepticism from some Republicans about her involvement in changing childhood vaccine recommendations. A senior…

White House pulls Heidi Overton's nomination to lead Food and Drug Administration: Report →
The Guardian18 Nov

The White House has withdrawn Heidi Overton’s nomination to lead the Food and Drug Administration after bipartisan concerns about her willingness to challenge President Trump’s policies, particularly regarding vaccines and abortion. Republican senator Bill Cassidy, who chairs the Senate health committee, had expressed reservations about her support for Trump’s vaccine plans and her stance on abortion rights…

White House withdraws nomination of Heidi Overton to lead FDA →
Daily Caller18 Nov

The Trump administration withdrew Heidi Overton’s nomination to lead the FDA on November 18, 2026, due to lack of support in the Senate. Overton, a physician and deputy director of the White House Domestic Policy Council, was nominated in August and faced opposition from Democrats, some Republicans, and MAHA activists. The White House cited the need for a more populist approach to health as the reason for the…

MAHA Rejoices After White House Drops Controversial FDA Nomination →
The Independent18 Nov

The White House has withdrawn Dr. Heidi Overton’s nomination to lead the Food and Drug Administration (FDA) just before a Senate committee vote scheduled for Wednesday. Overton, a physician with a history of opposing abortion, faced significant opposition from pro-life senators like Josh Hawley, as well as from senators like Susan Collins and Lisa Murkowski over her stance on abortion and her role in approving…

White House pulls Trump’s FDA nominee on eve of key Senate vote →

Where they agree and split

Framing

How the first headlines put it

Attributed to a source2
Stated as fact10
The headlines (12)

White House pulls FDA chief nominee Heidi Overton before hearing, Axios says The Straits Times · attributed to a source

White House pulls Heidi Overton's nomination to lead Food and Drug Administration: Report Just the News · attributed to a source

Trump administration weighs Marshall for FDA as Overton wobbles Semafor · stated as fact

Trump FDA nominee Heidi Overton struggling to win GOP support CBS News · stated as fact

White House withdraws Heidi Overton’s FDA nomination after Trump pick received bipartisan pushback New York Post · stated as fact

White House pulls FDA nominee Heidi Overton after wavering support from Senate Republicans Toronto Star · stated as fact

White House drops Heidi Overton’s FDA nomination NBC News · stated as fact

White House pulls Trump’s FDA pick Heidi Overton on eve of Senate panel vote Fox News · stated as fact

Trump's pick Heidi Overton dropped as nominee for FDA commissioner ABC News · stated as fact

White House withdraws nomination of Heidi Overton to lead FDA The Guardian · stated as fact

White House withdraws Heidi Overton’s nomination to become next FDA commissioner Washington Examiner · stated as fact

MAHA Rejoices After White House Drops Controversial FDA Nomination Daily Caller · stated as fact

The full story: what happened, how it changed, and all 17 articles →

Compared with similar articles

This article reads unscored and hedges 18% of its claims. Each row says how that neighbour differs.
New York Post
Leans left Hedges 0 of 7 claims Outlet record 66/100
The Guardian
Leans right Hedges 1 of 18 claims Outlet record 64/100
NBC News
Leans right Hedges 1 of 19 claims Outlet record 74/100
Washington Examiner
Hedges 0 of 2 claims Outlet record 67/100
The Independent
Leans right Hedges 6 of 23 claims Outlet record 59/100
CBS News
Hedges 1 of 4 claims Outlet record 66/100
The Daily Caller
Hedges 4 of 27 claims Outlet record 92/100
Toronto Star
Leans right Hedges 0 of 3 claims Outlet record 64/100
ABC News (US)
Leans right Hedges 0 of 4 claims Outlet record 66/100
Semafor
Hedges 3 of 8 claims Outlet record 64/100

Story

White House Withdraws Heidi Overton’s FDA Nomination
Politics · 17 article(s) covering the same event. Compare every outlet's account →
How this article was measured signals, leaning charts, publisher record, byline, topics and claims

Signals How these are calculated →

Claims extracted
17
sentences that state something as happening or true
Uncertain
18%
3 of 17 hedged ("reportedly", "may", "according to")
Leaning
not political
takes no side on a contested political question
Publisher signals
64/100
The Straits Times's corrections and hedging, across everything collected from it. Not a measure of accuracy.
Outlets on this story
17
Politics
Same framing elsewhere
1
articles that frame the event the way this one does
Analyzed 2026-11-18 · how these are computed

How this is being covered How these are calculated →

Article leaning vs. publisher reliability
Source leaning vs. consistency

Publisher

The Straits Times · 5666 article(s) · 7 correction(s) detected
Running correction rate · 7 correction(s)

Who wrote this

The Straits Times
3954 article(s) here · 1 carrying a prediction
Catherine, Britain’s Princess of Wales, will reflect on her experience with cancer and recovery in a documentary to be broadcast internationally in November, Kensington Palace said on Nov 21.
"Following a complaint filed with civil party status on May 13, 2025, a judicial investigation was opened into alleged sexual offences and is currently ongoing," the Paris prosecutor's office said in a statement •
“And there is nothing that will fill the void right now.”
Among other measures, the proposed legislation would make it a crime to possess or use batteries that do not meet safety standards and would ban storing batteries inside apartments.
WASHINGTON, Nov 21 - Democrats basking in their November 3 election wins will soon unveil an ambitious legislative agenda for the first 100 days and beyond, in a test of progressives' influence and Republicans' willingness to cooperate, as they take control of the US Congress on January 3. That agenda is likely to be unveiled in early December once a Senate leadership race is settled.
2026-11-21 · assertive framing · Democrats won big in the midterms. So now what?
Among other measures, the proposed legislation would make it a crime to possess or use batteries that do not meet safety standards and would ban storing batteries inside apartments.
At least 4 people were killed and 30 injured in a fire at a power station in southern Iraq on Saturday, with the toll expected to rise, security officials said.
Around 100 countries backed this position but big arms-producing nations like the US, Russia and Israel opposed this, resulting in a watered-down agreement that left open the question of whether future measures would be legally binding. "In the end, the military powers managed to impose many obstacles to the objective of a protocol, but at least it remains a possibility, and with a short-term mandate," said a diplomat who attended the talks that concluded past 4 a.m. (0300 GMT) in Geneva. The 128 member states of the Convention on Certain Conventional Weapons had been meeting since Monday as alarm grows over the use of lethal autonomous weapons systems in conflicts, including in Ukraine, Sudan and the Middle East.
The apparent compromise of the National Crime Information Center database would mark the second intrusion involving an FBI system in recent months and the latest in a string of cyber incidents that have alarmed US officials over the past week.
Electrify the world Australia’s Climate Minister Chris Bowen, who was shuttling between delegations to seek compromises, said he would work over the “coming hours, for as long as it takes, to get the job done”.
Also by The Straits Times
Nothing else under this byline is closely related to this article, so these are simply their most recent.
All 3954 articles by The Straits Times →

Topics

Axios FDA Senate The White House White House

Subjects

FDA ORG · 5× Overton PERSON · 5× Axios ORG · 3× White House ORG · 3× Heidi Overton PERSON · 2× Means PERSON · 2× Republican NORP · 2× Senate ORG · 2× The White House ORG · 2× Trump PERSON · 2×

Narrative

Maine Republican Senator Susan Collins said she had concerns about the FDA’s authorisation of fruit-flavoured vapes earlier in 2026 and Alaska Senator Lisa Murkowski expressed concerns about the agency’s approach to the abortion pill mifepristone.
framing: assertive · carried by 1 article(s) · first seen 2026-11-18
The withdrawal will extend a period of turmoil at the FDA, which regulates products that account for roughly a fifth of consumer spending in the US.
2026-11-18 · The Straits Times
White House pulls FDA chief nominee Heidi Overton before hearing, Axios says · assertive framing

Claims (17 extracted, 3 hedged)

White House pulls FDA chief nominee Heidi Overton before hearing, Axios says AI generated WASHINGTON – asserted
Axios → pull → hearing
The Trump administration has withdrawn White House aide Heidi Overton’s nomination to lead the US Food and Drug Administration (FDA), according to Axios, leaving the agency without a permanent commissioner as the political path to filling the post grows more complicated. uncertain
path → withdraw → post
The White House has dropped the bid due to lack of congressional support, Axios said, citing an unnamed senior administration official. asserted
Axios → drop → official
The Senate Health, Education, Labour and Pensions committee was slated to vote on Nov 18 whether to recommend Overton for a full floor vote. asserted
committee → slat → vote
She was the target of criticism from Calley Means, who recently left his job as one of Health Secretary Robert F. Kennedy Jr.’s top advisers. asserted
who → leave → advisers
In a scorched-earth campaign following his departure, Means claimed Overton opposed Kennedy’s policy goals on pesticides, food policy, vaccines and psychedelic treatments. asserted
Overton → scorch → pesticides
Senator Bill Cassidy, a Louisiana Republican who leads the Senate HELP committee, criticised Overton for helping craft President Donald Trump’s executive order proposing an overhaul of childhood vaccinations. asserted
who → lead → vaccinations
Maine Republican Senator Susan Collins said she had concerns about the FDA’s authorisation of fruit-flavoured vapes earlier in 2026 and Alaska Senator Lisa Murkowski expressed concerns about the agency’s approach to the abortion pill mifepristone. asserted
Murkowski → say → pill
The withdrawal will extend a period of turmoil at the FDA, which regulates products that account for roughly a fifth of consumer spending in the US. asserted
that → extend → US
Former Commissioner Marty Makary resigned in May after 13 months in the top role that were marred by clashes with staff and pushback from biotech companies. uncertain
that → resign → companies
Soon after, a wave of other senior leaders departed. asserted
wave → depart → leaders
It’s unclear whether the White House will be able to advance a nominee before Democrats take control of the Senate in January. uncertain
Democrats → ’ → January
Attorney Kyle Diamantas, who previously headed the agency’s food centre, is leading the FDA on a temporary basis. asserted
who → head → basis
The Trump administration has had several high-profile failed nominations for top health positions, including two for surgeon general and one to lead the Centres for Disease Control and Prevention. asserted
administration → have → Control
The surgeon general role remains unfilled; Erica Schwartz took the helm at CDC in August. asserted
Schwartz → remain → August
Overton is a deputy assistant to the president for domestic policy, focused on health issues. asserted
Overton → focus → issues
She worked at the think tank America First Policy Institute, is a medical doctor and has a doctorate in clinical investigation from Johns Hopkins University. asserted
She → work → University
Give feedback · no sign-in needed

No sign-in needed for now. Your note is sent without a name, so it cannot be answered.

History Support